Search

Panacea Biotec

Sector: Healthcare | Industry: Drugs & Pharma
R 160.25 -1.80  | -1.11% -51.06% - 985.22
NSE Price: Feb 18, 09:39 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Feb 18, 09:39 160.25 -1.80 -1.11% 161.95 162.05 4,270 158.45 - 161.95
BSE Feb 18, 09:56 159.50 -1.35 -0.84% 161.10 160.85 89 159.50 - 161.10
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 58,042 P/B: 4.32 NSE Code: PANACEABIO
52-Week Range: R 137.75 - 355.05 Dividend Yield: 0.00% BSE Code: 531349
TTM EPS: R -27.08 Book Value: R 37.27 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 34
Price Graph
  • Merck (NSE)
  • NIFTY 50


Please wait while we are fetching data...
Value Research Stock Advisor now has 34 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Panacea Biotec 1.19 2.92 1.92 -53.82 20.99 10.56 8.23
NIFTY Smallcap 100 -11.19 -11.20 -8.65 -32.17 8.11 12.68 13.77
NIFTY Pharma -2.54 -4.26 -6.24 -6.13 -8.25 2.27 14.97
Company's return has been calculated on basis of NSE's price.
As on Feb 15, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 8.97 -4.81 -0.52
Net Profit -34.95 7.91 10.86
EPS -35.78 9.28 10.99
Book Value -13.21 311.05 8.14
Average
Operating Margin 15.65 17.70 10.11
Net Margin -12.68 -8.45 -12.22
Return on Networth -22.94 -19.11 -77.37
Return on Investment 2.63 5.11 3.83
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -3.99 -25.18 -32.05
Operating Profit 407.46 -33.45 -37.23
Net Profit 76.39 -137.08 -169.24
EPS 76.39 -137.08 -169.24
TTM
Revenue -7.18 -15.24 -14.63
Operating Profit -24.28 -72.30 -66.09
Net Profit -8.72 -94.87 -130.79
EPS -8.72 -94.87 -130.79
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Panacea Biotec 985.22 495.10 -165.89 -31.99 -22.94 4.32 -
Merck 5,184.48 1,051.73 150.62 11.53 13.44 6.37 41.84
Wockhardt 4,344.43 4,197.51 -355.67 -8.38 -21.81 1.60 -
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 04, 2018 Rajesh Jain HUF  Sell Market 266,665 241.95 645.20
Sep 04, 2018 Rajesh Jain HUF  Sell Market 29,153 241.95 70.54
Apr 06, 2018 Ashwani Jain  Sell Market 21,360 303.55 64.84
Mar 28, 2018 Serum Institude Of India Pvt Ltd  Buy Open Market 320,137 267.15 855.25
Mar 19, 2018 Sunanda Jain  Buy Transmission 5,712,300 279.85 15,985.87
Fund Houses invested in the stock
Fund Dec-18 Sep-18 Jun-18 Mar-18 Dec-17
ICICI Prudential Mutual Fund 1.185 1.007 - - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Panacea Biotec Ltd.

Address: Ambala - Chandigarh Highway, Lalru, Punjab - 140501 | Phone: 01762- 505900 | Fax: 01762- 505909 / 505906

Email: [email protected]

Website: www.panacea-biotec.com

Registrar & Transfer Agent: Skyline Financial Services Pvt Ltd

Address: D-153/A, 1st Floor,Okhla Industrial Area, Phase - I, New Delhi - 110020, D-153/A, 1st Floor, Okhla Industrial Area, Phase - I | Phone: 91-011-26812682/84 | Fax: 91-11-26292681

Email: [email protected]

comments powered by Disqus
Essential checks
Altman Z-Score
0.83
Piotroski F-Score
4
Modified C-Score
2
5-Years Price to Earnings
Not applicable
5-Years Price to Book
4.32
Earnings Yield
EBIT / Enterprise value
-2.52%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R1,799.95 +1.26%
Caplin Point Laboratories R328.80 +1.09%
Dishman Carbogen Amcis R189.45 -0.79%
FDC R150.55 -0.86%
Laurus Labs R322.80 -1.41%
Merck R3,130.55 +0.28%
Shilpa Medicare R354.00 +1.53%
Strides Pharma Science R403.45 +0.32%
Sun Pharma Adv. Research R161.50 -1.19%
Wockhardt R390.85 -0.47%
As on Feb 18, 09:39